These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9127460)

  • 1. Development of a monoclonal antibody to urinary degradation products from the C-terminal telopeptide alpha 1 chain of type I collagen. Application in an enzyme immunoassay and comparison to CrossLaps ELISA.
    Fledelius C; Kolding I; Qvist P; Bonde M; Hassager C; Reginster JY; Hejgaard J; Frøokiaer H; Christiansen C
    Scand J Clin Lab Invest; 1997 Feb; 57(1):73-83. PubMed ID: 9127460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new monoclonal antibody ELISA for detection and characterization of C-telopeptide fragments of type I collagen in urine.
    Srivastava AK; MacFarlane G; Srivastava VP; Mohan S; Baylink DJ
    Calcif Tissue Int; 2001 Dec; 69(6):327-36. PubMed ID: 11800229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coated-tube radioimmunoassay for C-telopeptides of type I collagen to assess bone resorption.
    Bonde M; Fledelius C; Qvist P; Christiansen C
    Clin Chem; 1996 Oct; 42(10):1639-44. PubMed ID: 8855148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen.
    Rosenquist C; Fledelius C; Christgau S; Pedersen BJ; Bonde M; Qvist P; Christiansen C
    Clin Chem; 1998 Nov; 44(11):2281-9. PubMed ID: 9799755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
    Garnero P; Gineyts E; Riou JP; Delmas PD
    J Clin Endocrinol Metab; 1994 Sep; 79(3):780-5. PubMed ID: 8077361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides.
    Christgau S; Rosenquist C; Alexandersen P; Bjarnason NH; Ravn P; Fledelius C; Herling C; Qvist P; Christiansen C
    Clin Chem; 1998 Nov; 44(11):2290-300. PubMed ID: 9799756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunoassay for type I collagen alpha 1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosis.
    Garnero P; Delmas PD
    Bone; 2003 Jan; 32(1):20-6. PubMed ID: 12584032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen type II C-telopeptide fragments as an index of cartilage degradation.
    Christgau S; Garnero P; Fledelius C; Moniz C; Ensig M; Gineyts E; Rosenquist C; Qvist P
    Bone; 2001 Sep; 29(3):209-15. PubMed ID: 11557363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoassay for quantifying type I collagen degradation products in urine evaluated.
    Bonde M; Qvist P; Fledelius C; Riis BJ; Christiansen C
    Clin Chem; 1994 Nov; 40(11 Pt 1):2022-5. PubMed ID: 7955372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the clinical performance of the immunoenzymometric assays for N-terminal and C-terminal type I collagen telopeptides and the HPLC assay for pyridinium cross-links.
    Bettica P; Masino M; Cucinotta E; Vago T; Norbiato G; Moro L; Suarez KN; Romanello M; Bevilacqua M
    Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):63-8. PubMed ID: 9156570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen.
    Bonde M; Garnero P; Fledelius C; Qvist P; Delmas PD; Christiansen C
    J Bone Miner Res; 1997 Jul; 12(7):1028-34. PubMed ID: 9200001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone.
    Alexandersen P; Peris P; Guañabens N; Byrjalsen I; Alvarez L; Solberg H; Cloos PA
    J Bone Miner Res; 2005 Apr; 20(4):588-95. PubMed ID: 15765177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine.
    Hanson DA; Weis MA; Bollen AM; Maslan SL; Singer FR; Eyre DR
    J Bone Miner Res; 1992 Nov; 7(11):1251-8. PubMed ID: 1466251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of the Elecsys beta-CrossLaps serum assay, a new assay for degradation products of type I collagen C-tlopeptides.
    Okabe R; Nakatsuka K; Inaba M; Miki T; Naka H; Masaki H; Moriguchi A; Nishizawa Y
    Clin Chem; 2001 Aug; 47(8):1410-4. PubMed ID: 11468230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum osteocalcin and urinary crosslaps are suitable markers of bone turnover in response to short-term hormone replacement therapy.
    Peichl P; Griesmacher A; Müller MM; Marteau R; Kumpan W; Bröll H
    Gynecol Endocrinol; 2000 Oct; 14(5):374-81. PubMed ID: 11109977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of hormone replacement therapy in postmenopausal women on urinary C-telopeptide and N-telopeptide of type I collagen, new markers of bone resorption.
    Taga M; Uemura T; Minaguchi H
    J Endocrinol Invest; 1998 Mar; 21(3):154-9. PubMed ID: 9591210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of C-telopeptide enzyme-linked immunoassay for measurement of bone resorption in mouse serum.
    Srivastava AK; Bhattacharyya S; Castillo G; Miyakoshi N; Mohan S; Baylink DJ
    Bone; 2000 Oct; 27(4):529-33. PubMed ID: 11033448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding potency of peptide fragments of type 1 collagen cross-linked N-telopeptide measured by an enzyme-linked immunosorbant assay.
    Lung FD; Chen CH; Chen HY; Liou CC; Liou YM
    Protein Pept Lett; 2002 Oct; 9(5):451-7. PubMed ID: 12370034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and application of a serum C-telopeptide and osteocalcin assay to measure bone turnover in an ovariectomized rat model.
    Srivastava AK; Bhattacharyya S; Castillo G; Wergedal J; Mohan S; Baylink DJ
    Calcif Tissue Int; 2000 Jun; 66(6):435-42. PubMed ID: 10821880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes.
    Fassbender WJ; Gödde M; Brandenburg VM; Usadel KH; Stumpf UC
    Adv Med Sci; 2009; 54(1):1-6. PubMed ID: 19482729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.